Kevin D Freeman - Net Worth and Insider Trading
Kevin D Freeman Net Worth
The estimated net worth of Kevin D Freeman is at least $386,905 dollars as of 2024-04-19. Kevin D Freeman is the Director of Galectin Therapeutics Inc and owns about 114,469 shares of Galectin Therapeutics Inc (GALT) stock worth over $386,905. Details can be seen in Kevin D Freeman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin D Freeman has not made any transactions after 2022-10-28 and currently still holds the listed stock(s).
Transaction Summary of Kevin D Freeman
Kevin D Freeman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin D Freeman owns 1 companies in total, including Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of Kevin D Freeman’s form 4 insider trades.
Insider Ownership Summary of Kevin D Freeman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2022-10-28 | director |
Kevin D Freeman Latest Holdings Summary
Kevin D Freeman currently owns a total of 1 stock. Kevin D Freeman owns 114,469 shares of Galectin Therapeutics Inc (GALT) as of October 28, 2022, with a value of $386,905.
Latest Holdings of Kevin D Freeman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GALT | Galectin Therapeutics Inc | 2022-10-28 | 114,469 | 3.38 | 386,905 |
Holding Weightings of Kevin D Freeman
Kevin D Freeman Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin D Freeman has made a total of 18 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 18 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 10,000 shares on October 28, 2022, which cost Kevin D Freeman around $14,100.
Insider Trading History of Kevin D Freeman
- 1
Kevin D Freeman Trading Performance
GuruFocus tracks the stock performance after each of Kevin D Freeman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin D Freeman is 5.49%. GuruFocus also compares Kevin D Freeman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin D Freeman within 3 months outperforms 8 times out of 27 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin D Freeman's insider trading performs compared to the benchmark.
Performance of Kevin D Freeman
Average Return
-8.79%
Outperforming Transactions
33%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.19 | 5.49 | 1.26 | -8.79 | -12.15 | -15.56 |
| Relative Return to S&P 500(%) | 2.7 | 4.14 | 1.03 | -10.6 | -20.49 | -26.7 |
Kevin D Freeman Ownership Network
Ownership Network List of Kevin D Freeman
Ownership Network Relation of Kevin D Freeman
Kevin D Freeman Owned Company Details
What does Galectin Therapeutics Inc do?
Who are the key executives at Galectin Therapeutics Inc?
Kevin D Freeman is the director of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .
Galectin Therapeutics Inc (GALT) Insider Trades Summary
Over the past 18 months, Kevin D Freeman made 1 insider transaction in Galectin Therapeutics Inc (GALT) with a net purchase of 10,000. Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred ,
In summary, during the past 3 months, insiders sold 0 shares of Galectin Therapeutics Inc (GALT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Galectin Therapeutics Inc (GALT) were sold and 13,398 shares were bought by its insiders, resulting in a net purchase of 13,398 shares.
Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galectin Therapeutics Inc Insider Transactions
Kevin D Freeman Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin D Freeman. You might contact Kevin D Freeman via mailing address: 712 Lakeway Drive, Keller Tx 76248.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
